secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001380106-25-000050
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q4 revenue $8.2M (+30% YoY); gross margin turns positive; announces MilliporeSigma deal
--------------------------------------------------------------------------------

- Q4 2024 revenue $8.2M (up 30% vs $6.3M in Q4 2023); product revenue $5.2M (+27%), service revenue $3.0M (+35%).
- Q4 gross margin 12% (improved from negative 3% in Q4 2023); net loss $9.7M ($0.22 loss per share) vs $11.2M loss.
- FY 2024 revenue $28.1M (+25%); net loss $46.9M ($1.08 per share) improved from $52.5M loss in 2023.
- FY 2025 guidance: total revenue at least $32.0M with 21-25 system placements expected.
- Entered global Distribution & Collaboration Agreement with MilliporeSigma for co-exclusive rights to sell Growth Direct systems and consumables.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000050/0001380106-25-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000050/rpid-20250228.htm
  HTML page:      https://secwatch.observer/filing/0001380106-25-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer